Slingshot members are tracking this event:
FDA Grants Accelerated Approval to Ocaliva (Obeticholic Acid) for the Treatment of Patients with PBC
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
|ICPT||Community voting in process|
Slingshot Insights Explained
May 27, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Ocaliva, Obeticholic Acid, Pbc, Liver Diseases, Biliary Cirrhosis, Biliary Cholangitis, Ursodeoxycholic Acid, Farnesoid X Receptor, Bile Acid, Inflammatory